Functional temporomandibular pain syndrome Musculoskeletal Diseases
Conditions
Interventions
Single-centre interventional prospective parallel-group randomized (1:1) controlled trial with concealed allocation, assessor blinding, and an active control (standard rehabilitation alone) comparing
Sponsors
Palacký University Olomouc
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Adult patients with functional temporomandibular pain syndrome
Exclusion criteria
Exclusion criteria: 1. Structural TMJ disorders 2. Neurological disorders 3. Acute infection 4. Botulinum toxin application within the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective pain intensity in the TMJ region assessed using the Visual Analogue Scale (0–10) at baseline, 24 hours, and 1 month after the start of therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life is assessed using the WHOQOL questionnaire at baseline, 24 hours, and 1 month after the start of therapy 2. Range of motion is measured with a sliding millimetre ruler at baseline, 24 hours, and 1 month after the start of therapy | — |
Countries
Czech Republic
Contacts
Public ContactPetr Konecný
Outcome results
None listed